NCT02914548View on ClinicalTrials.gov

Study of OPA-15406 Ointment in Patients With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Atopic Dermatitis
Interventions
DRUG

OPA-15406

Subjects were treated with assigned 0.3% or 1% OPA-15406 ointment twice daily.

DRUG

Placebo

Subjects were treated with assigned 0% OPA-15406 ointment twice daily.

Trial Locations (3)

Unknown

Hokkaido Region

Kanto Region

Kiniki Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY